Michael Gilmore Wins Shark Tank Award to Advance Precision Therapy Against Drug-Resistant Bacteria
News
Michael Gilmore, PhD, is one of six winners of Mass General Brigham's inaugural Integrated Shark Tank competition.
Michael Gilmore, PhD
Content tagged with Michael Gilmore, PhD
Not finding what you're looking for? Try using Advanced Search.
Not finding what you're looking for? Try using Advanced Search.
Mass General Brigham Hosts 2025 World Medical Innovation Forum
News
On September 15-17, 2025 the World Medical Innovation Forum brought together nearly 2,000 leaders from industry, investment, government, and academia to explore the breakthroughs reshaping healthcare.
Michael S. Gilmore, PhD, Receives NIH P01 Grant for Antibiotic Resistance Program
News
Michael S. Gilmore, PhD, Sir William Osler Professor of Ophthalmology at Harvard Medical School and Chief Scientific Officer at Mass Eye and Ear, recently received a five-year, $11,409,360 Program Project (P01) grant from the National Institutes of Health...
Study Led by Michael Gilmore, PhD, Identifies Pathway for how Enterococcus Faecalis Bacteria Causes Antibiotic-Resistant Infection
News
A new study led by a research team from Harvard Medical School and Mass. Eye and Ear, describes how bacteria adapted to the modern hospital environment and repeatedly cause antibiotic-resistant bloodstream infections. This study examined one of the first...
Researchers develop new class of antibiotics to fight leading superbugs
News
In a significant advance against drug-resistant superbugs, investigators supported by the Harvard-wide Program on Antibiotic Resistance have identified a new class of synthetic antibiotics that have been shown to be effective against Staphylococcus aureus...
Michael Gilmore, PhD, gives national and international lectures in December
News
Michael Gilmore, PhD , Sir William Osler Professor of Ophthalmology, gave two lectures in December. On December 5, he presented the Annual Neal Groman Lecture at the University of Washington, where he spoke on the origins of leading multidrug resistant...
Antibiotic-resistant microbes date back to 450 MYA, well before the age of dinosaurs
News
Survival of mass extinctions helps to explain near indestructible properties of hospital "superbugs" Boston, Mass. — Leading hospital “superbugs,” known as the enterococci, arose from an ancestor that dates back 450 million years — about the time when...
Michael Gilmore, PhD, chairs $20 million antibiotic-resistance challenge
News
In March 2017, Michael Gilmore, PhD, Director of the Harvard Infectious Disease Institute, chaired a blue ribbon panel that reviewed the most promising applications for the Antimicrobial Resistance Diagnostic Challenge--a $20 million federal prize...
Honors and Awards Received in August and September, 2016
News
Faculty Recognition Dean Eliott, MD, Evangelos Gragoudas, MD, and Lucia Sobrin, MD, MPH, have been named members of the Ocular Surgery News "Retina 150" list. This is a select group of retinal specialists the editors and publisher have identified as...
Mass. Eye and Ear team discovers, successfully treats new variant of antibiotic-resistant bacterium
News
Boston, Mass. — Researchers at Massachusetts Eye and Ear have discovered a new mutation in a highly antibiotic-resistant strain of E. coli that resists clearance by the body’s own immune system by inhibiting white blood cells that ordinarily kill and...